Sensus Healthcare Expects 26% Reimbursement Change Tied to CMS Coding
In the third quarter, the company placed its 1,000th system and shipped more units directly to dermatology practices than in the previous two quarters combined.

Sensus Healthcare, Inc. management expects a 26% reimbursement change tied to hospital coding under the Centers for Medicare & Medicaid Services (CMS) to begin Jan. 1, 2027, as the company broadens sales to dermatology practices.
Management views the anticipated change as a catalyst. In the third quarter of 2026, Sensus shipped more systems directly to dermatology practices than in the previous two quarters combined and placed its 1,000th system.
Two large private equity-backed groups made initial purchases during the quarter. One bought systems, while the other chose Fair Deal.
Sensus’ third-quarter revenue fell 13% year over year to $6 million, primarily because of product mix and no sales to its historically largest customer. Gross margin increased to about 55% from 39%, mainly as the company shipped more higher-margin SRT-100 units.